Small molecule APIs remain the cornerstone of the pharmaceutical industry, resulting in an extremely competitive and crowded outsourced API manufacturing market. In a space where many providers offer similar capabilities, understanding how sponsors evaluate and differentiate CDMOs is increasingly important. This report provides a comprehensive view of sponsor outsourcing behaviors and provider selection criteria, while benchmarking leading CDMOs on the capabilities, qualities, and performance attributes that influence partner choice and competitive positioning.
What you will learn:
Outsourcing Practices
- Current outsourcing levels across manufacturing activities
- Contracting model used in outsourced projects
- Preferred provider engagement and management
CDMO Selection Drivers
- Key criteria influencing CDMO selection
- Selection attributes gaining importance
CDMO Perceptions & Interactions
- CDMO brand familiarity and usage
- Leadership, preference, and proposal volume
- CDMO cost perceptions
CDMO Performance & Competitive Landscape
- How CDMOs perform against sponsor expectations
- Satisfaction and likelihood to reuse/recommend
- Sponsor perceptions across competing providers
Company Service Quality Profiles
-
25+ CDMO profiles
-
Customer feedback on 23 performance metrics
-
Includes metrics such as Loyalty, Performance against Expectations, Satisfaction verbatim and more
Included Providers:
Companies listed in bold print have a Company Service Quality Profile page detailing company performance based on user ratings (currently using or have used in the past 18 months).
- AbbVie Contract Manufacturing
- AGC Pharma Chemicals
- Ajinomoto Bio-Pharma Services
- Almac
- Aragen
- Ardena
- Asymchem
- Axplora
- Bachem
- BioDuro
- Cambrex
- Carbogen Amcis
- ChemCon
- CordenPharma
- Curia
- Esteve
- Evonik
- Evotec
- Fareva
- GSK Contract Manufacturing
- Hetero
- Hovione
- Lonza
- MilliporeSigma
- Neuland
- Olon
- Patheon, by Thermo Fisher Scientific
- Pfizer CentreOne
- Piramal Pharma Solutions
- PROCOS
- Quotient Sciences
- Sai Life Sciences
- SEQENS
- Siegfried
- SK Pharmteco
- Sterling Pharma Solutions
- Syngene
- WuXi STA
- Yuhan CDMO
Respondents were required to pass several screening criteria to qualify and participate in this survey:
- Must work at a biopharmaceutical company
- Must have responsibilities in at least one of the following categories: clinical operations, clinical trial manufacturing, commercial manufacturing, executive management, outsourcing/purchasing management/supply chain, quality assurance/quality control, R&D management, regulatory compliance, or validation
- Must have been involved in outsourced Small Molecule API / drug substance manufacturing within the past 18 months




